When was Neurosoft Bioelectronics founded?

Neurosoft Bioelectronics was founded in 2019 and raised its 1st funding round 1 year after it was founded.

Where is Neurosoft Bioelectronics located?

Neurosoft Bioelectronics is headquartered in Geneva, Switzerland. It is registered at c/o c/o Nicolas Vachicouras, Chemin des Cornillons 94, 1292 Chambésy, CH.

Who is the current CEO of Neurosoft Bioelectronics?

Nicolas Vachicouras of Neurosoft Bioelectronics.

How many employees does Neurosoft Bioelectronics have?

As of Aug 31, 2026, the latest employee count at Neurosoft Bioelectronics is 24.

Is Neurosoft Bioelectronics a funded company?

Neurosoft Bioelectronics is a funded company, having raised a total of $20M across 7 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jan 28, 2020.

When was the latest funding round of Neurosoft Bioelectronics?

Neurosoft Bioelectronics' latest funding was a $***** Seed round on May 20, 2026, with participation from 3 investors. Its primary sector is Disease Self Management. In Switzerland, the Disease Self Management sector has seen $35.6M in funding in 2026 to date.

Where does Neurosoft Bioelectronics rank among its competitors?

Neurosoft Bioelectronics ranks 11th amongst 171 active competitors, of which 65 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was BrainCo, which secured an undisclosed amount in Sep, 2026.

Who are the top competitors of Neurosoft Bioelectronics?

Neurosoft Bioelectronics' top competitors include Ceribell, Empatica and Beacon Biosignals. Among them, BrainCo secured the most recent funding round in September, 2026.

Neurosoft Bioelectronics - 2026 Company Profile, Team, Funding & Competitors

Neurosoft Bioelectronics is a seed company based in Geneva (Switzerland), founded in 2019 by Florian Fallegger, Nicolas Vachicouras and Ludovic Serex. It operates as a Provider of soft implantable electrodes for neurological disorders. Neurosoft Bioelectronics has raised $20M in funding from Fongit. The company has 171 active competitors, including 65 funded and 6 that have exited. Its top competitors include companies like Ceribell, Empatica and Beacon Biosignals.

Company Details

Provider of soft implantable electrodes for neurological disorders. The company offers its proprietary technology SOFT ECoG which is a subdural electrode made up of thin metal films of sub-micron thickness to achieve long-term bio-integration in the body, conforming to the static and dynamic mechanics of neural tissue. The company claims that the product is still under development and is not approved for human use.

Website: www.neurosoft-bio.com/
Social
Email ID: *****@neurosoft-bio.com
Registered Address: c/o c/o Nicolas Vachicouras, Chemin des Cornillons 94, 1292 Chambésy, CH

Key Metrics

Founded Year

2019

Location

Geneva, Switzerland

Stage

Seed

Total Funding

$20M in 7 rounds

Latest Funding Round

Seed, May 20, 2026, $*****

Investors

Fongit & 7 more

Ranked

11^th among 171 active competitors

Employee Count

24 as on Aug 31, 2026

Similar Companies

Ceribell & 157 more

View Neurosoft Bioelectronics' full profile

Neurosoft Bioelectronics is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Neurosoft Bioelectronics SA CIN: 1448139 , Switzerland, Active	Apr 04, 2024	-	-	-

Neurosoft Bioelectronics has raised a total funding of $20M over 7 rounds. Its first funding round was on Jan 28, 2020. Its latest funding round was a Seed round on May 20, 2026 for $*****. 3 investors participated in its latest round. Neurosoft Bioelectronics has 8 institutional investors.

Here is the list of recent funding rounds of Neurosoft Bioelectronics:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 20, 2026	5997009	Seed	3421130	8289715	9758847	1829189
Mar 01, 2023	3832476	Grant (prize money)	8212270	8070450	1664667	Europa
Apr 05, 2022	4678842	Seed	7435928	8805052	Fongit	8715601

Access funding benchmarks and valuations. Sign up today!

View details of Neurosoft Bioelectronics's funding rounds and investors

The founders of Neurosoft Bioelectronics are Florian Fallegger, Nicolas Vachicouras and Ludovic Serex. Nicolas Vachicouras is the CEO of Neurosoft Bioelectronics.

Here are the details of Neurosoft Bioelectronics' key team members:

Florian Fallegger: Chief Scientific Officer and Co-Founder of Neurosoft Bioelectronics.
Nicolas Vachicouras: Co-Founder & CEO of Neurosoft Bioelectronics.
Contact Info: 2 email addresses
Ludovic Serex: Co-Founder & COO of Neurosoft Bioelectronics.
Contact Info: 1 email address

View details of Neurosoft Bioelectronics's Founder profiles and Board Members

Neurosoft Bioelectronics' employee count trend

Neurosoft Bioelectronics has 24 employees as of Aug 26. Here is Neurosoft Bioelectronics's employee count trend over the years:

Employee count trend for Neurosoft Bioelectronics

Uncover Neurosoft Bioelectronics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Neurosoft Bioelectronics include Ceribell, Empatica and Beacon Biosignals. Here is the list of Top 10 competitors of Neurosoft Bioelectronics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Ceribell 2014, Mountain View (United States), Public	EEG system for the diagnosis of seizures	$188M	The Rise Fund, Longitude Capital & 11 others	69/100
2nd	Empatica 2011, Milano (Italy), Series B	Developer of a wrist band to monitor physiological signals	$30.9M	RA Capital Management, Sanofi Ventures & 5 others	66/100
3rd	Beacon Biosignals 2019, Boston (United States), Series B	AI-based EEG analysis and diagnosis platform for healthcare providers	$141M	General Catalyst, Logos & 11 others	63/100
4th	BrainCo 2015, Somerville (United States), Series B	Provider of a prosthetic hand and EEG headband for brain signal	$292M	Walden International, IDG Capital & 10 others	58/100
5th	Emotiv 2011, San Francisco (United States), Seed	Manufacturer of wireless EEG headsets and software solutions	$7.41M	Disney Accelerator, The Wells Investment & 3 others	58/100
6th	BrainScope 2006, Bethesda (United States), Series B	Provider of AI-powered non-invasive medical devices for diagnosing and assessing brain injuries, including concussions and brain bleeds	$62.2M	Maryland Venture Fund, Aon & 11 others	58/100
7th	Epitel 2007, Salt Lake City (United States), Series B	Provider of a wearable EEG recording system for epilepsy monitoring and control	$38.5M	Genoa Ventures, CHV & 8 others	58/100
8th	Cumulus Neuro 2015, Belfast (United Kingdom), Series A	AI and cloud-based brain physiology analysis tool for clinical trials	$19.6M	Par Equity, Innovate UK & 29 others	57/100
9th	Epiminder 2018, Melbourne (Australia), Public	Developer of an implantable device for EEG monitoring	$24.5M	UniMelb, Cochlear & 3 others	56/100
10th	Spark Biomedical 2018, Houston (United States), Series A	Developer of wearable neurostimulation technology for drug-free opioid withdrawal treatment	$31.2M	Wave Ventures, Wellcome Leap & 5 others	56/100
11th	Neurosoft Bioelectronics 2019, Geneva (Switzerland), Seed	Provider of soft implantable electrodes for neurological disorders	$20M	IAG Capital Partners, MassChallenge & 6 others	56/100